NL1028599A1 - Compounds for the treatment of diseases. - Google Patents

Compounds for the treatment of diseases.

Info

Publication number
NL1028599A1
NL1028599A1 NL1028599A NL1028599A NL1028599A1 NL 1028599 A1 NL1028599 A1 NL 1028599A1 NL 1028599 A NL1028599 A NL 1028599A NL 1028599 A NL1028599 A NL 1028599A NL 1028599 A1 NL1028599 A1 NL 1028599A1
Authority
NL
Netherlands
Prior art keywords
diseases
compounds
treatment
Prior art date
Application number
NL1028599A
Other languages
Dutch (nl)
Other versions
NL1028599C2 (en
Inventor
Alan Daniel Brown
Mark Edward Bunnage
Paul Alan Glossop
Kim James
Charlotte Alice Louise Lane
Russell Andrew Lewthwaite
David Anthony Price
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL1028599A1 publication Critical patent/NL1028599A1/en
Application granted granted Critical
Publication of NL1028599C2 publication Critical patent/NL1028599C2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL1028599A 2004-03-23 2005-03-22 Compounds for the treatment of diseases. NL1028599C2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290770 2004-03-23
EP04290770 2004-03-23
US62502104P 2004-11-03 2004-11-03
US62502104 2004-11-03

Publications (2)

Publication Number Publication Date
NL1028599A1 true NL1028599A1 (en) 2005-09-26
NL1028599C2 NL1028599C2 (en) 2006-01-03

Family

ID=34961254

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1028599A NL1028599C2 (en) 2004-03-23 2005-03-22 Compounds for the treatment of diseases.

Country Status (5)

Country Link
AR (1) AR048322A1 (en)
NL (1) NL1028599C2 (en)
PA (1) PA8627001A1 (en)
TW (1) TW200533351A (en)
WO (1) WO2005092860A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1924553A1 (en) 2005-08-08 2008-05-28 Argenta Discovery Limited Bicyclo[2.2.]hept-7-ylamine derivatives and their uses
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
KR20100113557A (en) 2008-01-11 2010-10-21 노파르티스 아게 Pyrimidines as kinase inhibitors
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
PT2379507E (en) 2008-12-30 2014-01-21 Pulmagen Therapeutics Inflammation Ltd Sulfonamide compounds for the treatment of respiratory disorders
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US9102671B2 (en) 2011-02-25 2015-08-11 Novartis Ag Compounds and compositions as TRK inhibitors
MA44037B1 (en) * 2016-06-06 2020-03-31 Arena Pharm Inc Beta 3 adrenergic receptor modulators useful in the treatment or prevention of disorders associated therewith

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines
EP0220054A3 (en) * 1985-10-16 1987-12-02 Glaxo Group Limited Ethanolamine derivatives
ATE247641T1 (en) * 1996-11-14 2003-09-15 Pfizer PYRIDINE INTERMEDIATE PRODUCTS USABLE FOR PRODUCING BETA-ADRENERGIC RECEPTOR AGONISTS
TWI249515B (en) * 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
EP1477167A1 (en) * 2003-05-15 2004-11-17 Pfizer Limited [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists

Also Published As

Publication number Publication date
WO2005092860A1 (en) 2005-10-06
NL1028599C2 (en) 2006-01-03
PA8627001A1 (en) 2006-05-16
AR048322A1 (en) 2006-04-19
TW200533351A (en) 2005-10-16

Similar Documents

Publication Publication Date Title
NL1028599A1 (en) Compounds for the treatment of diseases.
NL1028598A1 (en) Imidazole compounds for the treatment of neurodegenerative diseases.
NL1028086A1 (en) Sulphonamide derivatives for the treatment of diseases.
NL1028087A1 (en) Sulfonamide derivatives for the treatment of diseases.
NL1026329A1 (en) 2-Amino-pyridine derivatives useful for the treatment of diseases.
NL1024499A1 (en) Thiazole compounds for the treatment of neurodegenerative disorders.
NL1026327A1 (en) 2-Amino-pyridine derivatives useful for the treatment of diseases.
NL1026203A1 (en) Compounds useful for the treatment of diseases.
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
NL1026892A1 (en) 11.8 Naphthyridin-2-ones and related compounds for the treatment of schizophrenia.
NL1030418A1 (en) Azabenzoxazoles for the treatment of CNS disorders.
NL1028664A1 (en) Sulfonamide compounds for the treatment of neurodegenerative diseases.
ITRM20050179A1 (en) APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES.
NL1033562A1 (en) Tetrahydropyridoazepine-8-ones and related compounds for the treatment of schizophrenia.
NL1032552C2 (en) Imidazole compounds for the treatment of neurological disorders.
GB0400802D0 (en) Compounds for the treatment of disease
NL1030417A1 (en) Azabenzoxazoles for the treatment of CNS disorders.
IL190182A0 (en) 2-aminoalcohols for the treatment of neurodegenerative diseases
ZA200606780B (en) Compounds for the treatment of diseases
NL1028600A1 (en) Compounds for the treatment of diseases.
NL1028597A1 (en) Formamide derivatives for the treatment of diseases.
NL1028559A1 (en) Compounds useful for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0415352D0 (en) Compounds for the treatment of disease

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20051102

PD2B A search report has been drawn up
VD1 Lapsed due to non-payment of the annual fee

Effective date: 20091001